Daniel Radiloff

Daniel Radiloff has extensive work experience in various roles within the fields of business development, research planning, program management, and laboratory management. Daniel'smost recent position was as the Director of Business Development at Pacific BioLabs, Inc. starting in October 2022. Prior to that, they served as the Business Development Director at TransCure bioServices from February to October 2022.

From 2018 to 2022, Radiloff worked at PhoenixBio Group, where they held the positions of Director of Research Planning and Business Development, as well as Manager of Research Planning and Business Development. During this time, they were responsible for strategic planning, project management, and budgeting.

Before that, Radiloff worked at Taconic Biosciences from 2016 to 2018 as a Scientific Program Manager. In this role, they managed a large portfolio of genetically engineered rodent model projects and acted as a subject matter expert and consultant for pre-clinical drug development.

From 2015 to 2016, Radiloff served as the Program Manager of Life Sciences at The New York Academy of Sciences. Daniel managed a diverse portfolio of international scientific conferences and meetings, developed scientific content, and served as a key liaison with stakeholders from academia, industry, and government.

Radiloff's earlier experience includes roles as a Postdoctoral Fellow at The University of British Columbia from 2012 to 2015, focusing on brain tumor metastasis and drug development, and as a Postdoctoral Fellow at Duke University from 2010 to 2012, where they worked on improving physical performance at high altitudes.

Daniel'scareer started as a Laboratory Manager at the University of North Carolina at Chapel Hill Department of Genetics from 2001 to 2003, where they conducted research in colon cancer susceptibility and managed mouse colonies. Radiloff also worked as an Analytical Chemist at Prism Laboratories, Inc. from 1997 to 2001, specializing in gas chromatography and trace metals analysis.

Radiloff began their career as a Research Intern at the Kathleen Price Bryan Family Fund from 1994 to 1997, conducting data research and logistics planning for grant funding to nonprofit organizations.

Throughout their career, Radiloff has demonstrated expertise in business development, research planning, program management, laboratory management, grant proposal writing, and scientific writing.

Daniel Radiloff completed their Bachelor of Arts degree in Biology at the University of North Carolina at Chapel Hill from 1989 to 1994. Subsequently, they pursued a Ph.D. degree in Molecular Cancer Biology and Pharmacology/Toxicology at Duke University, which they successfully completed from 2003 to 2009.